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CHAPTER 1: GENERAL INTRODUCTION 
 
Swine mycoplasmas are a common contributor to economic losses and adverse health in 
the pig industry (Sibila, 2009). Although several swine-specific mycoplasmas exist, only 
four are currently considered pathogenic. Mycoplasma hyosynoviae, Mycoplasma 
hyopneumoniae, Mycoplasma hyorhinis, and Mycoplasma suis are among the species 
that impact pigs clinically. This thesis will focus on M. hyosynoviae and M. 
hyopneumoniae, specifically. Although not understood to initiate disease alone, when 
combined with a primary viral or bacterial infection, both species trigger serious clinical 
disease in herds worldwide (Thacker, 2012).  
 
Mycoplasma hyosynoviae is a common cause of clinical arthritis in growing pigs. 
Carried in the tonsils, a stress event typically facilitates the systemic spread of the 
organism to the joints, with a predisposition for the stifle(s). Once in the joints, M. 
hyosynoviae is capable of causing a painful arthritis inducing anorexia-driven weight 
loss. Although antibiotic therapies are consistently used to treat mycoplasma-induced 
arthritis, both MICs and breakpoints for these antibiotics have not yet been established 
due to the fastidious nature of Mycoplasma hyosynoviae. Instituting breakpoint values 
for any bacteria requires a large number of isolates and subsequent in vitro MIC testing, 
neither of which has been performed due to the burdensome MIC testing techniques 
available (Turnridge, 2007).  Judicious use of antibiotics continues to be a major concern 
in food-producing animals, and the push for rational drug use begins with in vitro 
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antibiotic sensitivity testing.  Although several methodologies exist for determining 
antimycoplasmal activity of antibiotics, most diagnostic laboratories do not offer 
sensitivity testing of mycoplasma isolates. However, a more user-friendly, reproducible 
procedure was adapted from a previous study concerning Mycoplasma hyopneumoniae 
minimum inhibitory concentrations (Tanner, 1993). Both Tanner’s research and the 
original work presented in this thesis utilized a commercially-available product that 
allowed for a large number of isolates to be tested, with minimal preparation, yielding 
reportable results in less than one week. 
 
Mycoplasma hyopneumoniae is a common component of the Porcine Respiratory 
Disease Complex and the etiologic agent of enzootic pneumonia in pigs. Although 
several intervention strategies are available, the pork industry still struggles with 
economic loss and decreased animal welfare due to the disease.  Previous research has 
optimized both sample techniques and detection methods for Mycoplasma 
hyopneumoniae, however, the combination has not been utilized to assess herd 
prevalence of M. hyopneumoniae in the United States. Therefore, the prevalence of M. 
hyopneumoniae in the weaned pig population from four sow farms across Iowa was 
measured utilizing a novel tracheobronchial mucous collection technique and real-time 
polymerase chain reaction.
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The two capabilities of antemortem isolation of mycoplasmas and determination of in 
vitro antimicrobial susceptibility provide the necessary tools for development of clinical-
breakpoints for pathogenic mycoplasma. Breakpoint values are established by 
correlating the clinical outcome of a disease process after administration of a specific 
drug concentration.  Depending on resolution of clinical signs, the isolate is interpreted 
as susceptible, intermediate, or resistant.  The interpretive criteria allow for swine 
practitioners to make well-informed decisions on antimicrobial therapy specific for that 
isolate. The work reported here demonstrates that the potential for antemortem isolation 
of M. hyopneumoniae is improved with the use of tracheobronchial mucous collection. 
Combining this method with antibiotic susceptibility testing methods described by 
Tanner and Wu (1993), creating breakpoints for M. hyopneumoniae is possible. 
 
 Antemortem joint fluid collection is an effective way to isolate Mycoplasma 
hyosynoviae (Holt, in publication), however only cumbersome antimicrobial 
susceptibility assays are described for M. hyosynoviae. With the use of the susceptibility 
test described in Chapter 3 of this thesis, the institution of breakpoints for M. 
hyosynoviae is achievable. 
 
In conclusion, the use of the antemortem diagnostic tests developed in this thesis is 
valuable for treatment of diseases caused by swine mycoplasmas. Possible benefits to the 
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swine industry include early, guided therapeutic intervention leading to more prudent 
usage of antibiotics in swine herds nationally. 
Thesis Organization 
This thesis is organized into 5 chapters. The first chapter presents a general overview of 
swine mycoplasmas, specifically M. hyopneumoniae and M. hyosynoviae. Chapter 1 also 
briefly describes the antemortem tests developed in this thesis. The second chapter is a 
literature review on current standards for antimicrobial susceptibility assays and specific 
techniques utilized for Mycoplasma hyosynoviae. Chapter 2 also describes current 
measures to assess prevalence of Mycoplasma hyopneumoniae in a herd, including 
diagnostic assays and specific sample collection techniques. The third chapter defines 
the research completed on an in vitro antibiotic susceptibility test developed to help 
guide the prudent use of antibiotics to treat Mycoplasma hyosynoviae-induced arthritis.  
Chapter four details a novel antemortem testing technique to support a more accurate 
assessment of Mycoplasma hyopneumoniae herd prevalence. The final chapter 
summarizes the research results and offers input on how these antemortem evaluations 
may benefit the swine industry in the future.  
 
Expected Outcomes 
To date, Chapter 3, Optimization of an antibiotic sensitivity assay for Mycoplasma 
hyosynoviae and a sensitivity profile of field isolates from 1997-2010 was published 
in the Journal of Veterinary Microbiology Volume 158, Issues 1-2, 6 July2012, pages 
104-108 (http://dx.doi.org/10.1016/j.vetmic.2012.02.002). The abstract and content of 
 5 
the research was also presented at the 2011 American Association of Swine 
Veterinarians National Conference in Phoenix, AZ. One research poster has also been 
presented at the Iowa State University College of Veterinary Medicine Research Day in 
August 2010. 
The content of Chapter 4, Assessment of herd prevalence of Mycoplasma 
hyopneumoniae in pre-weaned piglets utilizing an antemortem tracheobronchial 
mucous collection technique and RT-PCR will be submitted in December 2013 to the 
Journal of Veterinary Microbiology for publication consideration. One Iowa State 
University MS thesis will be the final outcome of these bodies of work. 
 
Practical Implications 
The antemortem identification of the pathogen responsible for clinical signs and the 
strain-specific antibiotic profile are fundamental tools in guiding prudent use of 
antibiotics. The antemortem sample collection method currently utilized by the swine 
industry for M. hyopneumoniae is the nasal swab, and the diagnostic sensitivity remains 
questionable comparative to other antemortem techniques. Chapter three of the thesis 
described a novel antimicrobial sensitivity assay for United States M. hyosynoviae 
isolates modeled from an assay described for M. hyopneumoniae. The fourth chapter of 
the thesis evaluated an innovative antemortem sample collection technique for M. 
hyopneumoniae, tracheobronchial mucous collection, in an attempt to characterize 
prevalence of the pathogen in the pre-weaned piglet population. In conclusion, the use of 
the antemortem diagnostic tests developed in this thesis is valuable for treatment of 
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diseases caused by swine mycoplasmas. Possible benefits to the swine industry include 
early, guided therapeutic intervention leading to more prudent usage of antibiotics in 
swine herds nationally.  The product of this research will offer the global swine industry 
convenient antemortem diagnostic tools to help guide the prudent use of antimicrobial 
therapy against treatment of diseases caused by mycoplasmas. 
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CHAPTER 2 
LITERATURE REVIEW 
 
Mycoplasma hyosynoviae 
Antimicrobial susceptibility data are an important contributor to worldwide animal 
health by informing antibiotic recommendations, detecting potential antibiotic-resistant 
microorganisms, and producing data to further guide research efforts. The Clinical and 
Laboratory Standards Institute (CLSI) oversees and implements current laboratory 
standards regarding antimicrobial susceptibility procedures in an attempt to harmonize 
results globally to better serve the healthcare community. Mycoplasma hyosynoviae is 
considered a “fastidious” organism under the CLSI guidelines due to its difficult growth 
requirements and long incubation period (CLSI, 2008). For these same reasons, limited 
research exists with Mycoplasma hyosynoviae and its susceptibility to antibiotics.  
Global standardization has proven to be difficult for mycoplasma species in general due 
to the different methods employed by laboratories around the world, however, it still 
remains a fact that results need to be reproducible and consistent to allow for 
international data comparison (Hannan, 2000).  In 2012, an attempt was made to 
establish quality control ranges for two species of human mycoplasmas (M. pneumonia 
and M. hominis) through the collaboration of three different laboratories utilizing 
standardized testing methods. The CLSI approved the QC ranges if the MICs reported 
by all three labs fell within four, 2-fold dilutions of each other. Some antibiotic ranges 
were derived from the combined labs’ MIC data whereas some were unable to be 
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established (Waites, 2012). Quality control ranges for veterinary mycoplasmas, 
including Mycoplasma hyosynoviae, have not yet been described.  
 
To establish breakpoints for a species of bacteria, the CLSI recommends that the 
minimum inhibitory concentration (MIC) test be performed on 500 isolates 
representative of a globally diverse community and then correlated with a therapeutic 
outcome. Breakpoints offer more thorough data for practitioners as the formulation of 
breakpoints encompasses a pathogen-antibiotic relationship, taking into account 
pharmacokinetic data, disease pathogenesis, and outcome. Breakpoints for veterinary 
mycoplasma, including Mycoplasma hyosynoviae, have not yet been established. 
 
There are procedures described by the scientific community that measure minimum 
inhibitory concentrations for M. hyosynoviae, including the disc method assay, agar 
dilution, broth tube dilution, and broth microdilution, however, due to logistics of 
organism cultivation,  the preparation of antibiotic dilutions, and lengthy incubation 
periods, the current methods still remain inconvenient. They are described below. 
 
Disc-diffusion  
The disc assay involves a petri dish filled with growth agar specific for the bacteria.  The 
bacteria are plated onto the growth agar and paper discs saturated with different 
concentrations of antibiotic are then placed onto the agar. The zone of inhibition 
surrounding each disc correlates with the susceptibility of the bacteria to that particular 
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antibiotic.  However, because this is considered a qualitative test, an actual MIC cannot 
be determined; instead the isolate is classified as either susceptible, intermediate, or 
resistant. Friis and Szancer utilized this method for M. hyosynoviae isolates. The authors 
compared the results of the disc assay diffusion and a liquid medium test (described 
below) by measuring zones of inhibition and MICs for six strains of M. hyosynoviae 
isolated from Danish pigs against the following antimicrobials: enrofloxacin, 
lincomycin, tetracycline, tiamulin, and tylosin. Their results concluded that tiamulin 
inhibited the isolates at the lowest concentration with a MIC50 of 0.03µg/disc and a 
MIC50 of 0.025µg/mL for the disc assay and broth dilution, respectively (Friis, 1994). 
The authors suggest that, based on the results of their comparison, it may be possible to 
convert disc assay values into representative MIC values. However, several inaccuracies 
involving this method have been reported including inconsistent antibiotic disc 
concentrations and disparate agar thickness affecting zone inhibition measurements 
(Davis, 1971).  
 
Agar Dilution 
The agar dilution method requires the preparation of agar media containing different 
concentrations of a given antibiotic incorporated into each plate. A standard density of 
the bacterial isolate is then added to the plate and incubated for a given period of time. 
The number of colonies are calculated and/or evaluated at the time of growth, and the 
MIC is recorded as the lowest dilution of antibiotic completely inhibiting growth of the 
organism. Kobayashi and colleagues described this method for 54 field isolates of 
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Mycoplasma hyosynoviae isolated from Japanese pigs.  Of the 13 antibiotics tested in 
this study, only seven are approved for use in the United States. Their results show that 
tiamulin had the lowest MIC with an MIC90 of 0.05µg/mL. The results also show that the 
isolates were susceptible to tylosin with an MIC90 of 0.39µg/mL. An unexpected 
outcome was that the authors noted two field isolates of M. hyosynoviae completely 
resistant to all macrolides tested, including tylosin, erythromycin, and lincomycin 
(Kobayashi, 1996).  
Although considered more accurate than the disc assay, stringent preparation is 
necessary for the agar dilution method. In this procedure, the authors were required to 
prepare appropriate culture media and incorporate the agar into test plates, dilute the 
antibiotics from a stock solution into the appropriate test concentrations, and physically 
observe the plates for colonies of growth. Additionally, to avoid loss of potency, ideally 
the plates should be used on the day of preparation (Andrews, 2001). 
 
Broth Tube Dilution (Broth macrodilution) 
The broth macrodilution employs a similar concept as the agar dilution, but instead of 
antibiotic-laced agar, the given antimicrobial is added to the liquid broth media 
(Wiegand, 2008). Broth macrodilution testing utilizes a total broth volume of 
approximately 1-2ml in standard test tubes. Using this method, Aaerstrup and colleagues 
determined MICs for 42 Danish M. hyosynoviae isolates against enrofloxacin, 
lincomycin, tetracycline, tiamulin, and tylosin.  Half of the field strains were isolated 
between 1968-1971 and the other half from 1995-1996. Liquid media (1.8mL) for each 
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antibiotic concentration was added to a test tube and inoculated with 10
4
 CCU of each 
isolate in 0.2ml of media. The medium contained a pH indicator, phenol red; as the 
isolate metabolized an amino acid present in the media a shift to a basic pH occurred. 
Therefore, a color change from orange to red corresponded to isolate growth. Tiamulin 
had the lowest MIC and inhibited all isolates with an MIC of 0.0625µg/mL. The authors 
report complete sensitivity to tylosin of all strains isolated from 1968-1971 with an MIC 
range from 0.125µg/mL to 2µg/mL, however 12 of the 21 strains from 1995-1996 would 
be classified as relatively resistant (MIC range of 2µg/mL to 16µg/mL). The authors’ 
conclusion recommends the elimination of tylosin from Mycoplasma hyosynoviae-
induced arthritis treatment protocols (Aarestrup, 1998).   
 
Broth Microdilution 
A similar concept to broth macrodilution, microdilution uses smaller volumes of broth 
media (0.05 – 0.1mL). Zimmermann and Ross described this method in 1975 using 
twelve different antibiotics against twelve strains of M. hyosynoviae isolated from Iowa 
pig herds. Stock solutions of the twelve antibiotics were prepared at various 
concentrations in twofold serial dilutions. The authors utilized plastic microtiter plates 
with 0.10mL of growth media placed into each well. A standard amount (0.05mL) of 
each antibiotic at a specific concentration was added to designated wells and 0.05mL of 
test organism was added shortly after. All plates were sealed and incubated for two days 
until the positive control well showed growth using a dissecting microscope.  MICs were 
then recorded for each strain.  Tylosin, lincomycin, spectinomycin, and a combination of
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 lincomycin + spectinomycin had the lowest MIC ranges of the twelve isolates. The 
authors also reported a trend of potential tylosin-resistant organisms as the MICs of 
certain strains were at a high enough concentration that would unlikely be achieved in 
the bloodstream; however the results were not statistically significant (Zimmermann, 
1975). A similar study by Hannan and colleagues utilized a microtiter technique 
combined with a color-changing broth media for growth determination.  The MICs of 
seven field isolates of M. hyosynoviae were measured against the following antibiotics: 
valneumlin, tiamulin, tylosin, enrofloxacin, and oxytetracycline.  In this study, 
valnemulin had the lowest MICs against all M. hyosynoviae strains with an MIC range of 
0.0001-0.00025µg/mL, while the MIC range of tiamulin and enrofloxacin were 0.0025-
0.005µg/mL and 0.05-0.1µg/mL, respectively (Hannan, 1997).  
 
Although the data of the previous methods are in agreement that certain antibiotics have 
the lowest relative MICs, the actual MIC ranges vary. This information may be 
important when attempting to obtain therapeutic levels in the bloodstream or at the site 
of infection.  In order to follow CLSI guidelines to create QC ranges and clinical 
breakpoints, the antibiotic susceptibility testing methodology must be convenient, cost-
effective, and reproducible.  Although there are guidelines established detailing general 
suggestions regarding preparation of veterinary mycoplasma MICs throughout the 
different methods, it is still understood that standardization has not yet been achieved 
(Hannan, 2000). The previously described methods require strict management of 
mycoplasma cultures, tedious media preparation, and creating specific antibiotic 
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dilutions from stock solutions. When combined, these issues introduce a high potential 
for human error. Additionally, most of the MIC data for M. hyosynoviae has been 
performed outside of the United States on foreign isolates. Because extensive strain 
variation exists, recent data on the susceptibility of local isolates is indicated (Thacker, 
2012). If a standard method for performing M. hyosynoviae antimicrobial susceptibility 
testing is desired, the limitations of the current methods must be refined.  
 
Mycoplasma hyopneumoniae 
 Mycoplasma hyopneumoniae is the primary cause for enzootic pneumonia and is 
considered a primary pathogen in the porcine respiratory disease complex (PRDC). 
Affected pigs typically display a non-productive cough, lower average daily gain, 
decreased feed conversation and are predisposed to secondary pulmonary infections 
(Kobisch, 1996). Although several therapies exist to prevent and control infection, M. 
hyopneumoniae-induced pneumonia still remains a threat to the pork industry. It has 
been proposed that the specific timing of intervention strategies affects the outcome of 
disease spread (Meyns, 2004). However, in order to gain insight into proper timing of 
these strategies, an accurate diagnostic assessment of Mycoplasma hyopneumoniae 
infection is critical (Fablet, 2010). Research suggests that from nose-to-nose contact with 
the sow, piglets are colonized within a few days after birth (Thacker, 2012). However, 
highest transmission between penmates occurs at the time of weaning. A study in 2004 
quantified the transmission capability of Mycoplasma hyopneumoniae in weaned pigs by 
placing two experimentally infected pigs and six naïve pigs in the same pen for six 
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weeks (an attempt to simulate the nursery phase). The results showed that for every 
piglet infected with M. hyopneumoniae before weaning, another contact-infected piglet 
would result after weaning. Therefore, although the spread of M. hyopneumoniae is not 
rapid in the herd, the infection is perpetuated resulting in a higher number of infectious 
animals (Meyns, 2004). 
 
Mycoplasma hyopneumoniae diagnostics 
There are several diagnostic tools to determine the infection status of a herd, including 
bacterial isolation, enzyme-linked immunosorbent assay (ELISA), 
immunohistochemistry, and polymerase chain reaction (PCR) (Kobisch, 1996, Sorensen, 
1997). Although bacterial cultivation is considered the reference standard, this method is 
time-consuming and tedious (Friis, 1975). In a study by Sørensen and colleagues, the 
four diagnostic tests were compared for sensitivity and specificity throughout the course 
of an experimental M. hyopneumoniae infection. The results concluded that the 
specificities of all four tests were similar; however the sensitivities of PCR, antigen-
ELISA, and immunofluorescence were similar with that of cultivation at 14 and 28 days 
post infection (DPI). Conversely, over time, the negative predictive values of the 
molecular tests decreased with the increase in time post infection. Therefore, in cases of 
chronic infection, negative test results should be confirmed with cultivation.  However, 
the authors also concluded that, when using nasal swabs for detection, PCR is a superior 
testing method to cultivation as Mycoplasma hyopneumoniae was cultivated 0.5% at 
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Day 11 from nasal swabs, whereas PCR detected 14.2% positive nasal swab samples 
(Sørensen, 1997).  
 
The diagnostic test is not the only factor affecting the ability to find a positive sample in 
a herd. The sample collection method is also integral to the sensitivity and specificity of 
a diagnostic assay. Classically, diagnostic testing utilized by swine practitioners is 
conducted on samples collected post-mortem. However, monitoring the frequency of 
infection in live animals can provide valuable information on disease movement through 
a herd and consequently further guide therapeutic intervention strategies (Fablet, 2010). 
A correct antemortem diagnosis can be achieved if the individual or herd presents with 
clinical signs compatible with M. hyopneumoniae infection, other respiratory pathogens 
can be excluded, and confirmation of the presence of the organism through diagnostic 
assays is achieved. Due to convenience, nasal swabbing is the method of choice for 
antemortem M. hyopneumoniae detection in a herd. In fact, studies report the 
combination of PCR and nasal swabs to be a reliable method for M. hyopneumoniae 
detection (Otagiri, 2005,  Calsamiglia, 1999). However, alternative postmortem and 
antemortem sampling methods for M. hyopneumoniae detection have been analyzed. A 
study by Kurth and colleagues demonstrated that postmortem tracheobronchial brushing 
and bronchial alveolar lavage (BAL) fluid were the optimum sample sites to obtain a 
nested PCR positive test for experimentally-induced M. hyopneumoniae, and that both 
lung tissue and nasal swabs did not show similar sensitivity (Kurth, 2002). In a study by 
Fablet and colleagues, the outcome of four antemortem sampling methods, nasal 
 16  
swabbing, oropharyngeal brushing, tracheobronchial swabbing, and tracheobronchial 
washing were compared in naturally-infected pig herds. The samples were tested by both 
nested and real-time PCR. Their results showed that nasal swabbing was the least 
sensitive method of the four, as a significantly higher number of M. hyopneumoniae 
organisms were isolated with the other testing methodologies. The conclusions of the 
study suggest that antemortem tracheobronchial swabbing combined with real-time PCR 
is the optimum method for measuring herd infection (Fablet, 2010). In a similar study by 
Marois and colleagues, the authors report that either swabs or washes obtained from the 
trachea were the most effective samples at recovering M. hyopneumoniae organisms 
(Marois, 2007). 
  
Understanding herd prevalence of M. hyopneumoniae offers key information in the fight 
against enzootic pneumonia and, ultimately, PRDC. Guidance towards the timing of 
therapeutic intervention, changes to management procedures, and future research efforts 
are supported by understanding the presence of M. hyopneumoniae in a herd. It has been 
postulated that the major clinical differences seen in M. hyopneumoniae-infected herds is 
dependent upon the prevalence of the pathogen in the pigs at weaning (Fano, 2005). The 
prevalence of M. hyopneumoniae in the suckling pig population was examined in a study 
by Nathues and colleagues. Nasal swabs were sampled from piglets at the time of 
weaning and at 9 weeks of age. The authors reported a prevalence of 3.6% and 1.2% M. 
hyopneumoniae-infected piglets at weaning and at the end of the nursery phase, 
respectively (Nathues, 2013). Sibila et al (2007) also examined the prevalence of M.
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 hyopneumoniae in suckling pigs. A similar protocol revealed a prevalence of 1.5% and 
3.8% in pigs one week of age and three weeks of age, respectively (Sibila, 2007). There 
are several other studies focusing on the prevalence of M. hyopneumoniae in pig herds. 
Fano and colleagues utilized nasal swabs and a nested PCR technique to assess herd 
prevalence of M. hyopneumoniae in the weaned pig population. The results show that the 
prevalence of M. hyopneumoniae by litter (from 39 litters) ranged from 2.5% to greater 
than 50% (Fano, 2005).  
With optimized methods in both sample collection and detection techniques, a more 
accurate assessment of herd prevalence is available. In an attempt to focus efforts 
towards the combat of M. hyopneumoniae-induced production losses, the true dynamics 
of the disease needs to be established. Vaccination programs, antibiotic protocols, and 
management strategies have been in place for several years in an attempt to slow the 
progression of enzootic pneumonia; however the industry still struggles with economic 
loss.  
CONCLUSIONS 
Diseases caused by swine mycoplasma continue to negatively affect the swine industry. 
Although methods for detection and reduction of mycoplasmal disease are described, 
these techniques are limited in application. To change the way that disease management 
protocols are implemented, detecting the true prevalence of a disease in the population is 
fundamental. Based on this valuable information, in combination with prompt, farm-
specific antimicrobial sensitivity data, the timing of proper intervention is feasible.
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ABSTRACT 
Mycoplasma hyosynoviae is a common agent responsible for polyarthritis leading to 
decreased production in swine herds worldwide.  Antimicrobial agents are used to 
combat infections; however breakpoints for M. hyosynoviae have not yet been 
established.  A number of methods have previously been utilized to analyze minimum 
inhibitory concentrations (MICs) for antibiotics against M. hyosynoviae; however these 
techniques as currently described are not easily standardized between laboratories. A dry 
microbroth dilution method was conducted to compare the minimum inhibitory 
concentrations (MICs) for 18 antibiotics, representative of different classes, against 24 
recent isolates (23 field isolates and the type strain) of Mycoplasma hyosynoviae. The
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 MICs were determined using standard, commercially available 96-well Sensititre
® 
plates containing various freeze-dried antibiotics at a range of concentrations appropriate 
to their potency. Clindamycin (CLI), a lincosamide antibiotic, showed the highest 
activity and most consistent inhibition for all isolates with an MIC50 of ≤0.12 μg/ml. 
Tiamulin (TIA), a pleuromutilin derivative, exhibited an MIC50 of ≤0.25 μg/ml. The 
isolates had similar levels of susceptibility to the quinolones, enrofloxacin (ENRO) and 
danofloxacin (DANO), exhibiting an MIC50 of 0.25 μg/ml and 0.5 μg/ml, respectively. 
For the macrolides, the MIC50 for tylosin (TYLT) and tilmicosin (TIL) was ≤0.25 μg/ml 
and ≤2 μg/ml respectively, but was ≤16 μg/ml for tulathromycin (TUL). For the 
aminoglycosides, the MIC50 for gentamicin (GEN) was ≤0.5 μg/ml, while spectinomycin 
(SPE) and neomycin (NEO) had an MIC50 of ≤4 μg/ml. The tetracyclines, 
oxytetracycline (OXY) and chlortetracycline (CTET) both had an MIC50 of ≤2 μg/ml.  
Florfenicol (FFN) exhibited a MIC50 of ≤1 μg/ml.  All isolates were resistant to 
penicillin (PEN), ampicillin (AMP), ceftiofur (TIO), trimethoprim/sulfamethoxazole 
(SXT), and sulphadimethoxine (SDM) at all concentrations.  Within the isolates tested, 
there was a range of sensitivity detected, with some isolates being overall more resistant 
while others appeared more susceptible. Further research is required to demonstrate how 
this MIC data correlates to clinical efficacy of the various antibiotics in the field.  
 
INTRODUCTION
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Mycoplasma hyosynoviae, ubiquitous in swine populations worldwide, can play a major 
role in clinical lameness due to arthritis. It is a common isolate from the upper airways 
and tonsils of swine, and is spread by the respiratory route.  Although present in many 
herds, progression to disease varies and is typically associated with a predisposing stress 
event (Nielsen, 2001). Infection with M. hyosynoviae (with or without disease) typically 
occurs at 3-5 months of age. Recommendations for treatment include antibiotics and 
anti-inflammatory agents, and rational drug use decisions can be better informed by in 
vitro antimicrobial susceptibility assays. Because the incidence of M. hyosynoviae 
infections in the field anecdotally appears to be increasing, a better knowledge of 
effective treatment is indicated. 
There have been several reports examining the susceptibility of M. hyosynoviae to 
antibiotic agents (Friis, 1994, Hannan, 1997, Aarestrup, 1998, Kobayashi, 1996), though 
only one report exists that examines isolates from the United States (Zimmermann, 
1975). In addition, a number of methods have been reported in the literature describing 
in vitro antibiotic susceptibility to M. hyosynoviae including disc assay (Friis, 1994), 
agar dilution (Kobayashi, 1996), broth tube dilution (Aarestrup, 1998), and broth 
microdilution (Hannan, 1997 and Zimmerman, 1975).  However, these existing methods 
are cumbersome due to the extensive efforts necessary for preparation of antibiotic 
dilutions.  In order to find a more convenient approach, a method utilizing the Sensititre
® 
Standard Susceptibility MIC Plates BOPO-6F was adapted from a previous study that 
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determined the antimicrobial susceptibility of Mycoplasma hyopneumoniae isolates 
(Tanner, 1993). 
 
MATERIALS AND METHODS  
 
Twenty-three M. hyosynoviae field isolates were tested in this investigation. Each of the 
23 isolates were obtained from separate swine joint fluid samples submitted to the Iowa 
State Veterinary Diagnostic Laboratory from 1997-2011. The samples were confirmed 
positive for M. hyosynoviae by PCR (Blank, 1996). The reference strain, S16, was also 
included (Ross, 1970). All isolates were stored in 1ml aliquots at -80
o
C prior to use in 
modified Difco broth (Zimmermann, 1975) with 0.5% v/v L-arginine (Sigma-Aldrich).  
Ninety-six well, round-bottom microtitre plates containing stabilized freeze-dried 
antibiotics were used (BOPO-6F, Sensititre® Manufacturing, West Sussex, England). 
The manufacturer’s protocol was modified to add 100μL of culture rather than the 
suggested 50μL, in order to increase the intensity of the color change (the indicator of 
the MIC), which shifted the dilution range two-fold higher. Therefore, as tested, the 
plates contained the following antibiotic agents with their respective dilution ranges 
(μg/mL): ampicillin (0.12-8), ceftiofur (0.12-4), chlortetracycline (0.25-4), clindamycin 
(0.12-8), danofloxacin (0.06-0.5), enrofloxacin (0.06-1), florfenicol (0.12-4), gentamicin 
(0.5-8), neomycin (2-16), oxytetracycline (0.25-4), penicillin (0.06-4), spectinomycin (4-
32), sulphadimethoxine (128), tiamulin (0.25-16), tilmicosin (2-32), 
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trimethoprim/sulfamethoxazole (1/19), tulathromycin (0.5-32), and tylosin tartrate (0.25-
16). Three wells were left antibiotic-free to act as positive growth controls. 
Mycoplasma hyosynoviae isolates were cultured to log-phase as previously described 
(Ross et al., 1970).  For each plate, 1.5mL of each culture was diluted in 13.5 mL of 
sterile Difco media at pH 6.8, containing 0.5% L-Arginine (a known growth-promoter) 
and 0.1% phenol red (as a color indicator of pH). Each well of the BOPO-6F Sensititre® 
plate was inoculated with 100μL of the diluted M. hyosynoviae culture in modified Difco 
media solution. The plate was firmly sealed with a self-adhesive, transparent film to 
prevent evaporation. The plates were incubated between 2-5 days in a moist environment 
at 35°C ± 1°, until growth was evident in the control well.  
In addition to the BOPO-6F Sensititre® plates, a separate sterile Sensititre® plate 
containing no antibiotics was used to provide a visual control to assess growth. A 
medium control consisting of duplicate wells containing 100μL of sterile modified Difco 
media with 0.1% phenol red at pH 6.8 provided the a visual control for ‘no growth’.  A 
second set of duplicate wells containing 100μL of sterile modified Difco media with 
0.1% with phenol red adjusted to pH 7.3 using sterile I N sodium hydroxide provided an 
‘endpoint control’ indicating the pH of the media when it contains a positive logarithmic 
culture of M. hyosynoviae mock growth control. Additionally, four wells each containing 
100μL of the diluted M. hyosynoviae isolate under test in modified Difco media were 
included as true growth controls. The plate was firmly sealed with a self-adhesive, 
transparent film and incubated with the test plates. The growth control plates were 
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observed twice daily for pH-dependent color change. The antibiotic MIC determinations 
were made for each isolate when the color of its growth control approximated that of the 
endpoint of the mock growth control (equivalent to a pH shift from 6.8 to 7.3). The 
minimum inhibitory concentration (MIC) was recorded as the lowest concentration of 
each antibiotic to inhibit visible color change (Figure 1).  
As an estimate of reproducibility, each of the twenty field isolates was tested in 
duplicate. If the MICs varied by more than one log2 dilution, the highest concentration 
was reported. 
RESULTS 
The distributions of the MICs for the different M. hyosynoviae isolates are shown in 
Table 1. Clindamycin (CLI), a lincosamide antibiotic, showed the lowest MIC and most 
consistent inhibition for all isolates with an MIC50 of ≤0.12 μg/ml. Tiamulin (TIA), a 
pleuromutilin derivative, exhibited an MIC50 of ≤0.25 μg/ml. The isolates had similar 
levels of susceptibility to the quinolones, enrofloxacin (ENRO) and danofloxacin 
(DANO), exhibiting an MIC50 of 0.25 μg/ml and 0.5 μg/ml, respectively. For the 
macrolides, the MIC50 for tylosin (TYLT) and tilmicosin (TIL) was ≤0.25 μg/ml and ≤2 
μg/ml respectively, and was ≤16 μg/ml for tulathromycin (TUL). For the 
aminoglycosides, the MIC50 for gentamicin (GEN) was ≤0.5 μg/ml, while spectinomycin 
(SPE) and neomycin (NEO) had an MIC50 of ≤4 μg/ml. The tetracyclines, 
oxytetracycline (OXY) and chlortetracycline (CTET) both had an MIC50 of ≤2 μg/ml. 
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 Florfenicol (FFN) exhibited a MIC50 of ≤1 μg/ml.  All isolates were resistant to 
penicillin (PEN), ampicillin (AMP), ceftiofur (TIO), trimethoprim/sulfamethoxazole 
(SXT), and sulphadimethoxine (SDM) at all concentrations. 
 
REPRODUCIBILITY 
The four replicate MIC values obtained using the type strain S16 were either in 
agreement or one log2 dilution different from each other, with the exception of 
tulathromycin against strain S16 in which all the replicates were within two log2 
dilutions. Of the 23 field isolates tested, 9 individual replicate MICs varied by more than 
one log2 dilution: Isolate #3374 for chlortetracycline (two log2 dilutions), #3381 (three 
log2 dilutions), #3391A (three log2 dilutions), #3432 (two log2 dilutions), #3485 (two log2 
dilutions) for tulathromycin, #3391B for neomycin (two log2 dilutions), #3425 for 
chlortetracycline (three log2 dilutions), oxytetracycline (four log2 dilutions), and 
neomycin (two log2 dilutions), #3459 for tilmicosin (two log2 dilutions), and #3491 for 
florfenicol (two log2 dilutions). All remaining replicate MICs were either identical or 
within one log2 dilution. The isolates with MICs differing by more than 1 log2 dilution 
were tested a third time, and these results either agreed with the original MIC result or 
differed by 1 log2 dilution. Where replicate MIC values differed, the highest value is 
shown in the table. Tulathromycin MICs were the most inconsistent between all isolates, 
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which may reflect an unreliable interpretation of results with in vitro testing for this 
particular antibiotic.   
DISCUSSION 
Only a limited number of reports on MIC values for Mycoplasma hyosynoviae are 
available.  In the present study, MICs of 18 commonly-used antibiotics were determined 
for 24 M. hyosynoviae isolates using a modified dry microbroth dilution method. Isolates 
were submitted to the Iowa State Veterinary Diagnostic Lab between 1997-2011. As 
expected all 24 M. hyosynoviae isolates showed resistance to penicillin, ampicillin, and 
ceftiofur. β-lactams target the peptidoglycan layer of the cell wall, a structure lacking in 
the Mycoplasma species. All isolates were also resistant to the sulfonamides, 
trimethoprim/sulfamethoxazole and sulphadimethoxine, which target DNA replication 
through the inhibition of folate synthesis. It has been proven that a folate synthesis 
pathway
 
is lacking in Mycoplasma hyopneumoniae (Arraes, 2007), suggesting that 
Mycoplasma hyosynoviae also lacks this particular pathway. The 24 isolates showed a 
varying degree of susceptibility to the remaining 13 antibiotics which interfere with 
either protein synthesis or DNA replication (Table 2).  For gentamicin, tiamulin, and 
spectinomycin, all 24 isolates’ MICs were at the most concentrated dilution available on 
the Sensititre® plate; therefore the MIC values could have been lower than what was 
reported on the table. The modified method in this study which used twice the suggested 
volume shifted the lowest dilution 2-fold. Custom plates including more dilutions may 
be needed to facilitate determination of break-points for these antibiotics.
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Despite some variations in methods utilized, the MIC values obtained for the susceptible 
field isolated were in general agreement with reports from other investigators looking at 
similar antibiotics as this study (Aestrup et al., Hannan et al., Kobayashi et al.), however 
some major differences were noted. Tylosin tartrate, a macrolide antibiotic labeled for 
treatment of mycoplasma-induced arthritis, showed strong activity against all isolates, 
with MICs ranging between 0.25 μg/mL - 1μg/mL. This data contrasts previous studies, 
where resistance to this compound was reported (Aarestrup et al., 1998, Hannan et al., 
1997, Zimmerman et al., 1975). Lincomycin is labeled for treatment of mycoplasma-
induced arthritis; however, clindamycin is used as the representative lincosamide for 
MIC testing (CLSI 2008). Clindamycin showed the lowest MICs and most consistent 
activity, with 23 isolates susceptible at the 0.12 antibiotic concentration, and 1 isolate 
susceptible at the 0.25 antibiotic concentration. Under the conditions of this study, 
tulathromycin was the least bactericidal of the antibiotics targeting protein synthesis, as 
demonstrated by its wide range of MICs (1μg/mL- >32μg/mL) and 9 isolates showing 
growth at all dilutions tested.   
The results of this study provide new data regarding the susceptibility of recent United 
States M. hyosynoviae field isolates to a wide range of antibiotics. Unlike MIC testing 
for most bacteria, M. hyosynoviae in culture can require an incubation time between 2-5 
days before growth is noted. Eighty-five percent (85%) of the isolates grew within 4 
days, whereas 15% required 4 days or more before growth was noted (data not shown). 
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 Due to these conditions, the tested antibiotics might not remain active for the duration 
of the incubation period, thus causing an over-estimation of the true MIC. The clinical 
relevance of these finding are subject to confirmation of suitable bioavailability of the 
antibiotics by in vivo studies under both experimental and field conditions. In 
conclusion, the data presented for the 24 M. hyosynoviae isolates show that the 
adaptation of the broth microdilution technique using standard, commercially available 
plates offers a convenient and reproducible approach for determining minimum 
inhibitory concentrations of common antibiotics utilized in the swine industry. 
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CHAPTER 4: ASSESSMENT OF HERD PREVALENCE OF MYCOPLASMA 
HYOPNEUMONIAE IN PRE-WEANED PIGLETS UTILIZING AN 
ANTEMORTEM TRACHEOBRONCHIAL MUCOUS COLLECTION 
TECHNIQUE AND RT-PCR 
 
Abstract 
The purpose of this study was to determine the prevalence of Mycoplasma 
hyopneumoniae in the pre-weaned pig population utilizing tracheobronchial mucous 
collection and real-time PCR. Preliminary data was analyzed on weaned piglets with 
evidence of respiratory disease (n=32). Nasal swabs, antemortem tracheobronchial 
mucous collection (TBMC), postmortem deep airway swabs, bronchial alveolar lavage, 
and lung tissue was sampled from each piglet and a real-time PCR using three separate 
extraction methods was tested for each sample (32  pigs x 5 sample types x 3 extraction 
methods). Statistical analysis showed that both the sample collection technique and 
extraction method significantly affected the results (p < 0.0001 and p = 0.0063, 
respectively). Of the antemortem sample techniques, nasal swab and TBMC, pairwise 
comparisons showed a significant difference (p<0.0001) between CT results. Overall, 
the CT results from the nasal swab samples had the highest average least squares mean.  
Although not statistically significant from all five sample methods, tracheobronchial 
mucous collection showed the highest sensitivity with CT values showing the lowest 
average least squares mean. The results of the extraction method data revealed statistical 
significance comparing the three methods; however the high volume extraction 
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technique was chosen for simplicity in the laboratory technique. The tracheobronchial 
mucous was then pooled in quantities of 1:5 and 1:10; where one known positive sample 
was pooled with four and nine known negative samples, respectively. The CT results of 
the pooled data were compared with the original positive sample’s CT value. For the 
high volume extraction method, pooling the samples in a 1:5 dilution only changed the 
overall categorical outcome as positive or negative from the original sample one time out 
of nine samples. However, pooling the samples in a 1:10 dilution changed the outcome 
from the original sample three times. Pooling the samples at a 1:5 dilution was chosen 
for the field study protocol. Tracheobronchial mucous was collected from apparently 
healthy pre-weaned piglets (n = 1759) ranging in age from 12-25 days old from three 
separate sow farms in Iowa reporting respiratory issues downstream, however not 
currently showing any clinical signs of disease. Samples were pooled into groups of 5 
per litter and a real-time PCR using high volume extraction run on each pool. Only 2 out 
of 180 litters revealed a positive result (1.1%).  
 
Introduction 
Mycoplasma hyopneumoniae, the causative agent for porcine enzootic pneumonia (EP) 
and a key component in the porcine respiratory disease complex (PRDC), remains a 
major threat to the world’s swine industry (Sibila, 2009).  M. hyopneumoniae is 
considered to be one of the top sources of economic loss in the United States’ swine 
industry (Strait, 2008). Although M. hyopneumoniae vaccination protocols are widely 
implemented in US swine herds, mycoplasmal pneumonia still remains a threat to swine 
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production. However, it is apparent that not all herds are affected equally, and the 
difference has been equated to prevalence of M. hyopneumoniae in weaned pig 
populations (Fano, 2005). Studies suggest that the main risk factor for the development 
of disease is vertical transmission from sow to piglet during lactation and that the 
severity of the disease at slaughter may be predicted by the initial herd prevalence (Fano, 
2005). 
 
Simionatto et al (2013) suggests vaccination as the most cost-effective control measure 
against Mycoplasma hyopneumoniae pneumoniae. However, work by Thacker et al 
(2000) indicates that a concurrent PRRSV infection, either natural or from a modified 
live vaccine, reduces the efficacy of the M. hyopneumoniae bacterin vaccine. Because 
PRRSV is endemic in the United States, this data support the necessity for effective 
antimicrobial treatment options. There is research to support that antibiotic therapy is an 
effective method at control of clinical signs associated with enzootic pneumonia (Clark, 
1998). Previous research suggests the focus of control should aim to reduce prevalence 
in the sow herds which in turn may reduce spread of disease to piglets. However 
antemortem estimation of herd prevalence and the ability to obtain herd specific isolates 
for sensitivity testing is mandatory in order to establish baseline data to further support 
future research.  
 
The focus of this study is to refine antemortem mycoplasma detection and determine a 
baseline herd prevalence of Mycoplasma hyopneumoniae in the pre-weaned pig
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 population utilizing a novel antemortem sampling technique and to correlate this 
prevalence with sow age/parity. The information gained from this study will help guide 
methods of intervention to decrease the prevalence of Mycoplasma hyopneumoniae-
related disease in the swine population worldwide.  
 
Two diagnostic investigations were evaluated in this study. The first investigation 
identified a suitable protocol for both sample collection and diagnostic testing specifics 
for M. hyopneumoniae. The second investigation applied the protocol to three sow farms 
across the state of Iowa to assess herd prevalence of M. hyopneumoniae in the pre-
weaned piglet population. 
 
Materials and Methods 
Diagnostic Investigation #1 
Thirty-two weaned pigs from a sow farm in Iowa showing clinical signs of respiratory 
disease were transported to Iowa State University’s Veterinary Diagnostic Laboratory.  
A nasal swab and tracheobronchial mucous were sampled antemortem and 
oropharyngeal brushing, bronchial alveolar lavage, and lung tissue was collected post-
mortem from each pig. In an effort to identify the optimal sample site and PCR 
extraction method for detection of M. hyopneumoniae, a real-time PCR using three 
separate extraction methods (Viral, TNA, and High Volume) was run for each sample 
(32 pigs x 5 samples x 3 extraction methods) for a total of 480 PCRs. Pooling potential 
was assessed for the tracheobronchial mucous collection technique. Nine individual 
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samples were pooled at a 1:5 and a 1:10 dilution, where one known positive sample was 
pooled with 4 and 9 known negative samples, respectively.  The pooled CT values using 
the three extraction methods were compared with the original individual CT values.  
 
Diagnostic Investigation #2 
Enrollment of suitable herds 
 
Prior to investigation of each individual sow farm, an interview was conducted with the 
herd manager and/or veterinarian to gather information regarding herd health, history, 
antibiotic usage, and vaccine strategies to determine if a prevalence estimate would 
provide useful diagnostic information to manage the case. A farm was suitable for 
enrollment into the study if the herd met specific criterion. Each farm was required to 
have a minimum of twenty (20) gilt litters, twenty (20) litters from parity 2 or parity 3 
sows, and twenty (20) litters from sows currently in their fourth parity or greater on the 
farm in a single wean group. Usage of any antibiotics effective against Mycoplasma 
species in both the piglets and sows was prohibited for at least 3 weeks prior to 
sampling. These included, but were not limited to, tulathromycin, tylosin tartrate, 
enrofloxacin, gentamicin, florfenicol, chlortetracycline, lincomycin and tilmicosin. 
PRRSv status, average weaning age of piglets, and information regarding issues with 
respiratory disease downstream was also recorded for each farm.   
Design 
Lactating sows from each case farm were assigned a group number based on their 
current parity. Gilts (P1) were assigned to Group 1, sows in parity 2 or 3 (P2 or P3) were 
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assigned to Group 2, and sows in their fourth parity or above (P4+) were assigned to 
Group 3.  Each sow’s individual identification number and farrowing date were 
recorded. 
Up to ten (10) piglets from twenty litters per group from each sow farm were sampled 
for a possible total of 600 piglets per farm sampled (10 piglets x 20 litters x 3 groups). 
Ten piglets were sampled at random if more than ten piglets per litter were present. If 
less than ten piglets per litter were present, all piglets in the litter were sampled.  If more 
than 20 eligible litters per group were present on the farm, litters were sampled at 
random.  All sampled piglets were between 12-25 days of age.  
 
In this study, the litter was considered the experimental unit. Because M. hyopneumoniae 
is an infectious organism, any intervention aimed at combating the disease is performed 
at a litter level rather than individually. 
 
Sample Collection 
Each piglet to be sampled was identified and restrained using a hand snare placed over 
the maxilla. The piglet’s body was secured between the legs of the restrainer to ensure 
proper control of the piglet’s movement. The sample collector placed a speculum inside 
the piglet’s mouth and a 50 centimeter, 12 gauge, aspiration-type catheter (©Medinorm 
Medizintechnik GmbH, Germany) was inserted either through or under the speculum. 
The catheter was advanced until resistance was met indicating contact with the 
epiglottis. If the catheter entered the stomach at any time, the sample was discarded and
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 a new catheter was used. Upon piglet inspiration, the catheter was advanced further 
until a voice-change, cough, or wheeze was audible. This ensured proper placement of 
the catheter in the trachea. Once the catheter was properly placed inside the trachea, the 
catheter was advanced and retracted several times and rotated 360 degrees until adequate 
tracheal mucous was collected. The catheter was then retracted from the piglet’s mouth 
and the length of the catheter containing the sample was cut off and placed into a conical 
centrifuge tube (15mL Sterile Polypropylene Disposable Centrifuge Tube; Fisher 
Scientific, Pittsburgh, PA) containing 1mL of sterile 0.9% sodium chloride (©Hospira 
Inc., Lake Forest, IL). The sample tube was capped tightly, shaken forcefully to 
encourage the mucous to enter the saline from the catheter tip and placed on ice.  
Identification of Sample 
For the purposes of this study, each sample from an individual piglet was identified with 
a number printed on the transport media container (15mL Sterile Polypropylene 
Disposable Centrifuge Tube; Fisher Scientific, Pittsburgh, PA). This number correlated 
with the order in which the individual piglet was sampled in the litter. The numbering 
scheme began with one (1) and continued sequentially until the predetermined number 
of animals had been sampled in the litter.  Each litter was assigned ten sample collection 
tubes.  If there were less than ten piglets in a litter, all piglets in the litter were sampled 
and the number of each empty sample collection tube was recorded.  Each individual 
piglet was only sampled once. The subsequent sow farm sampled continued the 
numbering scheme, henceforth no two pigs sampled had the same sample number.
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Sample analysis 
All samples were stored on ice after collection and transported back to Iowa State 
University Veterinary Diagnostic Laboratory (ISU VDL). Samples were pooled in 
groups of five per litter so that all litters had two pools of samples. If the litters had less 
than ten piglets, the first five samples in the litter were pooled together and the 
remaining samples were then pooled. Each sample pool was analyzed using a validated 
RT-PCR technique at ISU VDL utilizing a high volume extraction technique.  Briefly, 
150µl from each sample was extracted from the individual tube and pooled with four 
other samples (or the remaining samples) from the same litter. A modified lysis buffer 
(450µl) was added to a 96-deep well plate and 300µl of the pooled sample was added to 
the wells. The plate was sealed with an aluminum seal and mixed for 3 minutes. The 
plate was then centrifuged for six minutes at 2500xg. Extraction was performed with the 
MagMax extraction kit and amplification was performed with the Kingfisher 96 PCR 
machine.  Each individual sample was then frozen at -80˚C for possible future testing. 
The results of both PCR tests were recorded for each litter. If either pooled PCR 
identified a positive sample, the entire litter was considered positive for Mycoplasma 
hyopneumoniae.  
 
RESULTS 
The PCR results from the first diagnostic investigation can be found in Table 3. A linear 
mixed model was conducted with the CT values as the response variable, the method of 
PCR extraction and sample collection technique as the fixed effects, and the individual 
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pig selected as the random effect. Results showed that sample collection method had an 
overall effect on the PCR’s CT value (p < 0.0001). Pairwise comparisons revealed a 
significant difference between the nasal swab technique and the other four sampling 
methods (Table 4). The nasal swab and tracheobronchial mucous collection technique (p 
< 0.0001) and nasal swab and the deep airway swab technique (p < 0.0001) showed 
significance. The pairwise comparison p-values for the bronchial alveolar lavage and 
lung sample versus the nasal swabs were 0.0004 and 0.0013, respectively.  The least 
squares mean CT value for the tracheobronchial mucous collection technique was lowest 
compared to the other four sample collection methods (Table 4). This suggests the 
presence of a higher amount of bacterial nucleic acid present in the tracheobronchial 
mucous requiring fewer rounds of DNA amplification, therefore this technique was 
chosen for the field trial. Additionally, using the high volume extraction method, 17 
piglets with a negative nasal swab CT result tested positive utilizing the tracheobronchial 
mucous collection technique (Table 5).  The linear mixed model also showed that 
extraction method had an overall effect on the PCR’s CT value (p = 0.0063). The 
interaction between extraction technique and sample collection method was not 
significant (p = .7555). Pairwise comparisons of extraction technique revealed a 
significant difference between the viral and the TNA extraction method (p = 0.0459). 
Pairwise comparisons between viral and high volume extraction methods and high 
volume and TNA extraction methods were not statistically significant (Table 6). 
Although the least squares mean CT value was lower using the TNA technique (Table 
6), due to cumbersome laboratory techniques, the high volume extraction method was 
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chosen for the field study protocol. The results of the pooling statistics indicated that 
when pooling the samples at a 1:5 dilution and using the high volume extraction method, 
the overall categorical outcome of the CT value (as positive or negative) only changed 
one time. However, pooling the samples at a 1:10 dilution changed the overall outcome 
three times. Due to economic issues, pooling the samples at a 1:5 dilution was chosen for 
the field protocol. The results for each dilution and extraction method are summarized in 
Table 7. Statistical analysis was completed using JMP 10, SAS Institute. 
 
The M. hyopneumoniae PCR results from the pooled litters from each sow farm can be 
found in Table 8. Of the 180 litters sampled from three sow farms, only two litters 
returned positive PCR results (one litter from Sow Farm 1 and 2).  
 
Discussion 
Understanding the prevalence of Mycoplasma hyopneumoniae in the swine population is 
important information when considering management of herd outbreaks. This 
information may also lay the groundwork for future research efforts. Nasal swabs have 
been the method of sample collection in the past for antemortem herd detection. 
However, there have been several studies reporting the use of more sensitive sampling 
techniques for detecting M. hyopneumoniae by PCR (Kurth, 2002, Marois, 2007, Sibila, 
2007). These sampling methods, although more sensitive, are conducted postmortem. 
Results indicate that ideal sampling sites are located in the lower respiratory tract of 
pigs, thus a sample targeting the trachea and bronchi are more likely to yield M.
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 hyopneumoniae organisms (Fablet, 2010). Because the organism is known to target 
ciliated respiratory epithelium, sampling areas composed of this tissue seems intuitive. 
Fablet and colleagues reported a technique that combines both antemortem testing 
capabilities with increased sensitivity; tracheobronchial swabbing proved to be 3.5 times 
more sensitive than nasal swabbing (Fablet, 2010). To date, no research has applied this 
novel sampling technique to assess prevalence of M. hyopneumoniae in U.S. swine 
herds. In a previous study, prevalence of M. hyopneumoniae in the weaned pig 
population using nasal swabs showed extremely low prevalence of the pathogen in the 
field (Fano, 2005). If a more sensitive sampling technique is utilized, it is hypothesized 
that the prevalence of M. hyopneumoniae is actually higher in the field than originally 
believed.  
 
The results of both diagnostic investigations presented in this original research suggest 
that tracheobronchial mucous collection is the most sensitive antemortem test available 
to assess true prevalence of M. hyopneumoniae in the pig population. The overall 
prevalence in the pre-weaned pig population from this study was low (1.1%) and in 
agreement with Nathues et al (2013) published prevalence of 3.6% in the weaned pig 
population. There are several possibilities for these findings. The results of the study 
indicate that either i) the piglets were truly negative for M. hyopneumoniae, ii) pooling 
methods diluted out the sample, or iii) the sample collection technique failed.
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The age range of the piglets sampled varied between 12-25 days of age. Because the 
piglets were not yet weaned, it is possible that maternal antibodies were still circulating 
when sampled. It is has been shown that antibodies decrease the adhesion capabilities of 
the bacteria to ciliated epithelium (Wallgren, 1998) and that the average half-life of 
maternal antibodies to M. hyopneumoniae is 15.8 days (Morris, 1994).  Although it is 
suggested that M. hyopneumoniae can be isolated in pigs as early as one week old, it is 
shown that prevalence increases with age, peaking at around the late nursery to early 
finishing stage (Sibila, 2007). Therefore, it is possible that the piglets sampled were truly 
negative for Mycoplasma hyopneumoniae. Instead of targetting piglets at the age of 
weaning, it may be more fitting to assess the prevalence of M. hyopneumoniae in 
nursery-age piglets. In this scenario, it is likely that the combination of recent stressful 
events (weaning, movement, commingling) in addition to waning maternal antibody may 
initiate higher bacterial loads in the herd. 
 
In classical statistical models for disease diagnosis or confirmation, the sensitivity and 
specificity of a diagnostic test along with the estimated prevalence of disease in the 
population is necessary for determining the sample size. Prevalence of disease in a 
population is often hypothesized based on clinical signs, environmental factors, and 
immunologic status of the population. This study aimed to provide the true prevalence of 
Mycoplasma hyopneumoniae in the pre-weaned pig population. Although the sample 
size was arbitrarily determined due to lack of supporting evidence of prevalence and test 
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sensitivity,  a large sample population of n = 180 litters hoped to provide for more robust 
data for statistical analysis. Previous studies suggest low prevalence of M. 
hyopneumoniae in younger age piglets, therefore, based on population diagnostic 
methods, an increased sample size is necessary for an accurate assessment of true 
prevalence. Moreover, it is possible that the population of pigs sampled in this study did 
not include those piglets infected with M. hyopneumoniae. The experimental unit in this 
study was the litter, and the sample size was 180. However, with a 95% confidence 
interval and an estimated prevalence of 50% (which gives the highest sample size), the 
recommended sample size would be 370. Although this study’s sample size did not 
reach 370, based on what is known about M. hyopneumoniae infection dynamics, it is 
unlikely that the estimated prevalence in the population sampled is 50%. A more feasible 
estimation of M. hyopneumoniae prevalence in the pre-weaned pig population may be 
10%, in which case with a 95% confidence interval the recommended sample size is 
137. This study’s sample size exceeded this number indicating that M. hyopneumoniae-
positive animals would have likely been identified. 
 
It has been suggested that herd outbreaks of M. hyopneumoniae occur at younger ages 
when a concurrent viral infection, such as PRRS virus is also in the herd (Thacker, 
1999). Similarly, research proposes that bacterial load and subsequent clinical disease 
increases when the bacteria interacts with any other respiratory pathogen, viral or 
bacterial.  In the current study, although there were some reports of respiratory issues in 
the downstream flow, the three sow farms were not experiencing clinical signs of 
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respiratory disease at the time of sampling.  To further assess this possibility, future 
research should involve sampling herds currently experiencing respiratory issues, 
especially those exhibiting clinical signs consistent with enzootic pneumonia.  
 
Another prospective reason for negative sample results may be attributed to pooling. As 
stated, the contents of five individual samples were combined and the resulting sample 
pool was PCR tested. It is possible that the amount of DNA in the pooled sample was 
diluted out as so the number of cycles to detect the organism exceeded the cutoff value 
of a positive sample. However, this is highly unlikely as one of the two pooled groups 
returning a positive PCR test had each individual sample PCR tested. Only one 
individual sample from the pool of five returned a positive PCR test (results not shown). 
This indicates that one individual positive sample in a pool of five negative sample still 
resulted in an overall positive pooled sample. Nevertheless, in an attempt to eliminate 
the potential of over dilution in the future, 0.5mL of sterile saline instead of 1mL should 
be placed into each conical centrifuge tube.  
 
It is also possible that our sample collection method either failed to gather sufficient 
sample material or the catheter was inserted into the incorrect location. However, these 
possibilities are also highly unlikely as the real-time PCR test is extremely sensitive and 
inserting the catheter into the trachea yields a consistent physical response from the 
piglet sampled. As the catheter contacts the epiglottis an obvious voice change occurs. 
Once the larynx opens and the catheter is inserted into the trachea, the piglet typically
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 instinctually reacts by excessively struggling in an attempt to regain air flow. 
Additionally, the length of the catheter is not easily inserted in its entirety into the 
trachea and bronchi, whereas if the catheter inadvertently is placed into the stomach, it is 
possible to advance the entire length of the catheter.   
 
In conclusion, tracheobronchial mucous collection is an innovative technique to achieve 
an accurate assessment of prevalence of M. hyopneumoniae in a pig herd. The benefits 
of this technique include the ability to diagnose a herd without the need to conduct a 
necropsy, and then based on the antemortem diagnosis, select a suitable intervention 
prior to fulminant herd infection. Further benefits of tracheobronchial mucous collection 
include the capacity to access a more appropriate sample location, the ease of the sample 
collection, and the benign quality of the process. Out of 1,759 piglets sampled in this 
study, there were zero deaths attributed to sample collection. The low disease prevalence 
reported in this study is consistent with research performed by Nathues et al (2013) and 
Sibila et al (2007). The 2013 study reported a M. hyopneumoniae prevalence of 3.6% in 
the weaned pig population utilizing nasal swabs for sample collection and nested-PCR 
for detection, while the 2007 reported a prevalence of 3.8% in three week-old piglets. A 
report by Vicca et al (2002) measured the disease prevalence in 6-week old pigs 
clinically infected with enzootic pneumonia. Using nasal swabs and nested PCR, the 
authors found a disease prevalence of 16%.  Although, this study did not sample litters 
clinically infected with respiratory disease, future research efforts will likely show an 
increase in M. hyopneumoniae prevalence in herds showing clinical signs of disease, 
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suggesting that both age and disease state may play an important role in detecting herd 
prevalence of M. hyopneumoniae. To date, there are no reports of tracheobronchial 
mucous collection technique performed on older pigs (growing, finishing stage). This 
technique would be easily adapted to sampling larger pigs, allowing insight into 
infection dynamics across the entire farrow-to-finish process.
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CHAPTER 5: GENERAL CONCLUSIONS 
The judicious use of antibiotics in food-producing animals has become more of a 
problem in recent years due to a higher number of cases involving antimicrobial resistant 
organisms. There are several ways to ensure that practitioners make appropriate, 
evidence-based decisions on suitable antibiotic protocols for use in herd treatment of 
disease. The antemortem identification of the pathogen responsible for clinical signs and 
the strain-specific antibiotic profile are fundamental tools in guiding practical use of 
antibiotics.  Previous tools to measure antibiotic susceptibility for Mycoplasma 
hyosynoviae include disc assay diffusion, agar dilution, broth tube dilution, and broth 
macrodilution (Friis, 1994,  Kobayashi, 1996, Aarestrup, 1998, Zimmermann, 1975,  
Hannan, 1997). Although the assays produce consistent results, the techniques are 
cumbersome and laborious. Tools to detect herd infections of Mycoplasma 
hyopneumoniae include both antemortem and postmortem methods. The antemortem 
sample collection method currently utilized by the swine industry is the nasal swab, and 
the diagnostic sensitivity remains questionable comparative to other antemortem 
techniques (Fablet, 2010).  
Chapter three of the thesis described a novel antimicrobial sensitivity assay for United 
States M. hyosynoviae isolates modeled from an assay described for M. hyopneumoniae 
(Tanner, 1993). The assay utilized the Sensititre® BOPO-6F antimicrobial plate 
containing various concentrations of freeze-dried antibiotics used in both bovine and 
porcine medicine. The utility of the commercially-available plate allows for a more 
convenient and reproducible approach to antibiotic sensitivity testing. 
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The fourth chapter of the thesis evaluated a novel antemortem sample collection 
technique for M. hyopneumoniae, tracheobronchial mucous collection, in an attempt to 
characterize prevalence of the pathogen in the pre-weaned piglet population. The results 
agree with previously published data that the prevalence of M. hyopneumoniae is low in 
weaned piglets (Nathues, 2013, Sibila, 2007). The value of this sample collection 
method allows for antemortem detection of M. hyopneumoniae in a pig herd with the 
added benefit of increased diagnostic sensitivity (Fablet, 2010).  
Antemortem collection of mycoplasmas combined with antimicrobial susceptibility data 
allow for clinical outcomes and MICs to be determined on the exact same isolate of 
mycoplasma. This highly related data allows for the determination of breakpoint values 
for veterinary mycoplasmas. Breakpoint values allow for more informed therapeutic 
protocols suggesting whether or not a specific isolate is likely to respond to the specific 
antimicrobial therapy. Breakpoints for veterinary mycoplasmas have not yet been 
established; however the tools described in this thesis make this possible and a logical 
next step.  
In conclusion, the use of the antemortem diagnostic tests developed in this thesis is 
valuable for treatment of diseases caused by swine mycoplasmas. Possible benefits to the 
swine industry include early, guided therapeutic intervention leading to more prudent 
usage of antibiotics in swine herds nationally.
                                        
 
Figure 1. Endpoint result of a BOPO-6F Sensititre® plate from one Mycoplasma hyosynoviae isolate. Pink well: M. 
hyosynoviae isolate growth uninhibited; Orange well: M. hyosynoviae isolate growth inhibited. 
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Table 1. Minimum inhibitory concentrations for 18 antibiotics against 21 Mycoplasma hyosynoviae isolates 
 
Class of Antibiotic Specific Agent MIC RANGE 
(μg/mL) 
MIC50 (μg/mL) 
Aminoglycoside Gentamicin 0.5 0.5 
 Neomycin 2.0 – 8 ≤ 4 
 Spectinomycin 4 4 
Amphenicol Florfenicol 0.25 – 4 ≤1 
β – Lactam Ceftiofur* ≥ 4 ≥ 4 
Lincosamide Clindamycin ≤ 0.12 – 0.25 ≤ 0.12 
Macrolide Tilmicosin ≤ 2 – 32 ≤ 2 
 Tulathromycin 1 - ≥ 32 ≤ 16 
 Tylosin Tartrate ≤ 0.25 – 1 ≤ 0.25 
Penicillin Ampicillin* ˃ 8 ˃ 8 
 Penicillin* ˃ 4 ˃ 4 
Pleuromutilin Tiamulin ≤ 0.25 ≤ 0.25 
Quinolone Danofloxacin 0.25 – 0.5 0.5 
 Enrofloxacin 0.12 – 0.5 0.25 
Sulfonamide Sulphadimethoxine* ˃ 128 ˃ 128 
 Trimethoprim/ 
Sulfamethoxazole* 
˃ 1/19 ˃ 1/19 
Tetracyclines Chlortetracycline 0.5 - ˃ 4 ≤ 2 
 Oxytetracycline 0.5 - ˃ 4 ≤ 2 
 
*Resistant at all available concentrations on the BOPO plate
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TABLE 2. Mechanism of action for the 18 antibiotics in the BOPO-6F plate 
DISRUPTS BACTERIAL CELL 
WALL 
AFFECTS BACTERIAL 
PROTEIN SYNTHESIS 
PREVENTS DNA 
REPLICATION 
Ampicllin Chlortetracycline Danofloxacin 
Cefiofur Clindamycin Enrofloxacin 
Penicillin Florfenicol Sulphadimethoxine 
 Gentamicin Trimethoprim/sulfamethoxazole 
 Neomycin  
 Oxytetracycline  
 Spectinomycin  
 Tilmicosin  
 Tulathromycin  
 Tylosin tartrate  
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Table 3. Percent M. hyopneumoniae PCR positive* by Extraction Method and Sample type 
EXTRACTION 
METHOD 
LUNG NASAL SWAB DEEP AIRWAY 
SWAB 
TRACHEOBRONCHIAL 
MUCOUS 
BRONCHIAL 
ALVEOLAR 
LAVAGE 
VIRAL 46.9% (15/32) 6.25% (2/32) 46.9% (15/32) 59.3% (19/32) 46.9% (15/32) 
TNA 46.9% (15/32) 6.25% (2/32) 46.9% (15/32) 59.3% (19/32) 59.3% (19/32) 
HIGH VOLUME 50% (16/32) 6.25% (2/32) 46.9% (15/32) 59.3% (19/32) 46.9% (15/32) 
TOTAL 47.9% (46/96) 6.25% (6/96) 46.9% (45/96) 59.3% (57/96) 51% (49/96) 
*PCR positive = CT < 37, PCR negative = CT ≥ 37 
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Table 4. Predicted least squares mean of CT values for five sample collection techniques for M. hyopneumoniae 
 
Sample Collection 
Technique 
    
Predicted least squares mean 
CT 
Nasal Swab A    37.6 
Lung  B   32.5 
Bronchial Alveolar Lavage  B C  32.1 
Deep Airway Swab   C D 30.2 
Tracheobronchial Swab    D 29.0 
        Levels not connected by the same letter are significantly different (p < 0.05) 
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Table 5. Comparison of PCR test results for the nasal swab and tracheobronchial mucous collection (TBMC) sample 
technique using the RT-PCR high volume extraction method 
 
SAMPLE NASAL SWAB TBMC SAMPLE NASAL SWAB TBMC 
1 - - 17 - + 
2 - - 18 - + 
3 - - 19 - + 
4 - - 20 + + 
5 - - 21 - + 
6 + + 22 - + 
7 - + 23 - + 
8 - - 24 - + 
9 - - 25 - + 
10 - - 26 - + 
11 - - 27 - + 
12 - + 28 - + 
13 - - 29 - + 
14 - - 30 - + 
15 - - 31 - + 
16 - - 32 - + 
Negative PCR result (-) = CT ≥ 37 
Positive PCR result (+) = CT < 37 
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Table 6. Predicted least squares mean of CT values for three PCR extraction methods for M. hyopneumoniae 
 
PCR Extraction Method   
Predicted least squares mean 
CT 
Viral A  32.9 
High Volume A  32.1 
TNA  B 29.5 
       Levels not connected by the same letter are significantly different (p < 0.05) 
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Table 7. Agreement of CT results from 1:5 and 1:10 dilutions with original CT value as positive or negative* by 
extraction method 
 
SAMPLE EXTRACTION METHOD ORIGINAL CT 1:5 DILUTION 1:10 DILUTION 
1 HIGH VOLUME +   
2 HIGH VOLUME +   
3 HIGH VOLUME +   
4 HIGH VOLUME +   
5 HIGH VOLUME +   
6 HIGH VOLUME +   
7 HIGH VOLUME +   
8 HIGH VOLUME +   
9 HIGH VOLUME +   
1 TNA +   
2 TNA +   
3 TNA +   
4 TNA +   
5 TNA +   
6 TNA +   
7 TNA +   
8 TNA +   
9 TNA +   
1 VIRAL +   
2 VIRAL +   
3 VIRAL +   
4 VIRAL +   
5 VIRAL +   
6 VIRAL +   
7 VIRAL +   
8 VIRAL +   
9 VIRAL +   
TOTAL   25/27 16/27 
*Negative PCR result (-) = CT ≥ 37       = CT results agree that sample was positive 
Positive PCR result (+) = CT < 37       = CT results showed a negative CT value
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Table 8. Percent M. hyopneumoniae Positive (+) Pooled PCRs* by Group and Sow Farm 
 
SOW FARM % PCR (+) Group 1 % PCR (+) Group 2 % PCR (+) Group 3 Total Number of 
Piglets Sampled 
#1 0/40 pools = 0.0% 1/40 pools = 2.5% 0/40 pools = 0.0% 590  
#2 0/40 pools = 0.0% 0/40 pools = 0.0% 1/40 pools = 2.5% 591 
#3 0/40 pools = 0.0% 0/40 pools = 0.0% 0/40 pools = 0.0% 578 
TOTAL 0.0% 2.5% 2.5% 1,759 
*PCR positive (+) = CT < 37, PCR negative = CT ≥ 37 
5
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